Skip to site content

CRS 2023 (v23.0)

CRS VERSION 23.0

CRS Version 23.0 is expected to be released in February 2023.

View the CRS 2023 (v23.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 1.4 MB]

View the CRS 2023 (v23.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 966 KB]

Key enhancements included in CRS Version 23.0 are shown below.

  • Logic Changes to National GPRA/GPRAMA Report Measures 
    • GPRA Developmental Measures: 
      • Added the following GPRA Developmental topic: 
        • Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes 
      • Removed the following GPRA Developmental topics:
        • Diabetes: Blood Pressure Control
        • Screening, Brief Intervention, and Referral to Treatment (SBIRT)
      • Removed measures from Adult Immunizations topic and moved to GPRA report. 
      • Updated codes and/or logic in the following measures: Childhood Immunizations; Suicide Risk Assessment; Appropriate Medication Therapy after a Heart Attack; HIV Screening; HIV Quality of Care; Sexually Transmitted Infection (STI) Screening; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines.
    • Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Removed POV E78.00 from hypercholesterolemia definition. (2) Changed ASCVD definition to an active diagnosis or an ASCVD procedure ever. (3) Removed pregnancy as a denominator exclusion. (4) Added denominator exception for patients with documentation of a medical reason for not being prescribed statin therapy. (5) Updated hospice indicator and palliative care definitions. (6) Updated medication taxonomy BGP PQA STATIN MEDS.
    • Influenza: Changed measure for patients 18 years and older to a GPRAMA measure. 
    • Adult Immunizations: (1) Updated age ranges. (2) Updated pneumococcal measures and logic to match previous GPRA Developmental measures. (3) Removed Zostavax vaccine from logic and measures. 
    • Childhood Immunizations: Removed POV codes 042.0 through 044.9 and R75 from HIV definition. 
    • Cancer Screening: Mammogram Rates: Added POV code Z12.31 and CPT codes 77061 through 77063 and G0279 to mammogram definition. 
    • Screening, Brief Intervention, and Referral to Treatment (SBIRT): Updated measures to include telemedicine visits (previous GPRA Developmental logic). 
    • Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Removed POV E78.00 from hypercholesterolemia definition. (2) Changed ASCVD definition to an active diagnosis or an ASCVD procedure ever. (3) Removed pregnancy as a denominator exclusion.(4) Added denominator exception for patients with documentation of a medical reason for not being prescribed statin therapy. (5) Updated hospice indicator and palliative care definitions. (6) Updated medication taxonomy BGP PQA STATIN MEDS.
    • HIV Screening: Removed POV codes 042.0 through 044.9 and R75 from HIV definition.

CRS 2023 Documentation

CRS 2023 (v23.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 1.4 MB]

CRS 2023 (v23.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 966 KB]

Selected Measures Report Performance Measure List and Definitions [PDF - 1.9 MB]

Elder Care Report Performance Measure List and Definitions [PDF - 993 KB]

IPC Measures Report Performance Measure List and Definitions [PDF - 600 KB]